SearchPublisher and Institutes
You are here: Home :: Keyword index :: gen bis Hyd :: health professional card - heart-type fatty acid binding protein (H-FABP) 
Heart failure
Items for "Heart failure"
Cardiac resynchronisation therapy: Effects on myocardial perfusion at rest, after vasodilation and oxygen consumption
Aim: Cardiac resynchronisation therapy (CRT) has been shown to improve haemodynamics and clinical symptoms in heart failure patients...
Keywords: Herzinsuffizienz, Linksschenkelblock, Perfusion, Sauerstoffverbrauch, PET
01/2006 | Nuklearmedizin, SchattauerDetermination of ventricular volumes in coronary artery disease: Comparison of two gated SPECT analysis tools with MRI
Aim: Comparison of two gated SPECT analysis tools gated SPECT quantification (GSQ) and emory cardiac toolbox (ECT) in patients with coronary artery disease (CAD) and severely impaired left ventricular function (preoperative: EF <35% by cardiac catheter)...
Keywords: GatedSPECT, kardiale Volumetrie, kardiale MRT, Myokardnarbe, koronare Herzerkrankung, Herzinsuffizienz
01/2006 | Nuklearmedizin, SchattauerUse of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
Keywords: antibody multispecificity, Heart failure, plasma immunoreactive BNP-32, point-of-care test, radioimmunoassay, solid-phase extraction
10/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterAtrial natriuretic peptide and related peptides
In recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases...
Keywords: Acute coronary syndrome, atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), dendroaspis natriuretic peptide (DNP), Heart failure, renal failure
10/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterAnalytical and clinical performance of three natriuretic peptide tests in the emergency room
Keywords: diagnosis, dyspnoea, Heart failure, natriuretic peptides, renal failure
05/2007 | Clinical Chemical Laboratory Medicine, Walter de GruyterTransesophageal left ventricular posterior wall potential in heart failure patients with biventricular pacing / Transsophageales linksventrikulres Potenzial der posterioren Wand bei Patienten mit Herzinsuffizienz und biventrikulrer Stimulation
Introduction: Biventricular (BV) pacing is an established therapy for heart failure (HF) patients with intraventricular conduction delay, but not all patients improved clinically...
Keywords: biventricular pacing, cardiac resynchronization, Heart failure, interventricular delay, left ventricular electrocardiography, biventrikulre Stimulation, Herzinsuffizienz, interventrikulres Delay, kardiale Resynchronisation, linksventrikulre Elektrographie
04/2007 | Biomedizinische Technik, Walter de GruyterExpressed genome molecular signatures of heart failure
Traditional gene expression studies typically focus on one or a few genes of interest...
Keywords: cardiovascular diseases, gene expression profile, Heart failure, microarray
05/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterLong-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
The aim of the present study was to assess the long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in plasma samples stored at –20°C without addition of protease inhibitors (e.g., aprotinin)...
Keywords: Evaluation, Heart failure, natriuretic peptides, Plasma, stability
08/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterAnalytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010
Methods to quantify B-type natriuretic peptide (BNP) and N-terminal-propeptide (NT-proBNP) in plasma or serum samples are well established...
Keywords: brain natriuretic peptide (BNP), Heart failure, natriuretic peptides, N-terminal proBNP (NT-proBNP)
11/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterAnalytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method
The aim of this study was to evaluate the analytical performance of a recently available immunoassay for brain natriuretic peptide (BNP), based on microparticle enzyme immunoassay (MEIA, AxSYM System, Abbott Laboratories), whose analytical characteristics and clinical results were compared with those of a point of care testing (POCT) method (TRIAGE system, Biosite Diagnostics)...
Keywords: brain natriuretic peptide, cardiac natriuretic hormones, Heart failure, microparticle enzyme immunoassay system, point of care testing method
10/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterConcentrations of N-terminal pro-brain natriuretic peptide and troponin T in plasma of 75-year-old apparently healthy persons
Clinical chemical reference values for older persons are sparse and mostly intermixed with those for younger persons...
Keywords: Heart failure, N-terminal pro-brain natriuretic peptide (NT-proBNP), prognostic marker, reference interval, troponin T
12/2004 | Clinical Chemical Laboratory Medicine, Walter de GruyterHomocysteine and heart failure: a review of investigations from the Framingham Heart Study
High plasma homocysteine levels are associated with a moderately increased risk of cardiovascular disease, particularly of atherosclerotic events...
Keywords: epidemiology, Heart failure, homocysteine, left ventricular hypertrophy
10/2005 | Clinical Chemical Laboratory Medicine, Walter de GruyterIncreased homocysteine in heart failure: a result of renal impairment?
Keywords: Heart failure, hyperhomocysteinemia, renal function
11/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterIschemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
Cardiovascular disease is the leading cause of mortality and morbidity in Western countries...
Keywords: Heart failure, ischemia-modified albumin, myocardial ischemia, natriuretic peptides, Peripheral arterial disease
02/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterClinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay
The clinical relevance of brain natriuretic peptide (BNP) and N-terminal (NT)-proBNP assays as a diagnostic tool and prognostic marker in patients with cardiovascular diseases has recently been confirmed...
Keywords: Acute coronary syndrome, atrial natriuretic peptide (ANP), biological variation, brain natriuretic peptide (BNP), cardiac function, cardiac natriuretic hormones, cardiovascular diseases, Heart failure
04/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterPrognostic value of homocysteinemia in patients with congestive heart failure
Keywords: ejection fraction, Heart failure, homocysteinemia, NYHA classification, Prognosis
07/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterClinical relevance of non-cardiac determinants of natriuretic peptide levels
There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides) plasma concentration may be elevated in many clinical conditions besides cardiovascular diseases, the most frequent being lung diseases, renal and liver failure, acute cerebrovascular events, acute and chronic inflammatory diseases and certain metabolic and endocrine disorders...
Keywords: diagnostic accuracy, Heart failure, natriuretic peptides, renal failure
11/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterNatriuretic peptide testing in primary care patients
The evaluation of cardiac endocrine function by means of automated robust assays has permitted the introduction of a cheap and powerful clinical tool...
Keywords: B-type natriuretic peptides, diagnosis, Heart failure, primary care, Prognosis, screening
11/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterCoenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy
Keywords: antioxidants, Cardiomyopathy, coenzyme Q10, C-reactive protein, Heart failure, oxidative stress
03/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterFree fatty acids as a cardiovascular risk factor
Free fatty acids (FFAs) serve as physiologically important energy substrates and their release from the adipose tissue by lipolysis is regulated according to the energy demands of the body...
Keywords: atherosclerosis, cardiovascular diseases, epidemiology, free fatty acids (FFAs), Heart failure, non-esterified fatty acids (NEFAs)
04/2008 | Clinical Chemical Laboratory Medicine, Walter de GruyterGenetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney
Tissue kallikrein (KLK1) is a kinin-forming serine protease synthesized in many organs including arteries and kidney...
Keywords: cardiac ischemia, diabetic nephropathy, endothelial function, Heart failure, ion transport, vasodilatation
06/2008 | Biological Chemistry, Walter de GruyterSide effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants
Keywords: Angiotensin converting enzyme inhibitor, Heart failure, hypotension, infant, Newborn, renal failure
09/2008 | Journal of Perinatal Medicine, Walter de Gruyter